The partnership brings together Salipro’s tech for stabilising drug targets from Boehringer’s drug discovery programmes.

The New Normal Five years ago, COVID-19 was declared a global pandemic, marking the official onset of a healthcare crisis ...

AstraZeneca’s senior director in oncology data science outlined how the company uses AI for drug discovery at a recent talk.

The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development.

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

A discovery about how severe COVID-19 damages lung cells suggests that an existing drug could treat lingering respiratory ...

One of the world’s leading Parkinson’s disease scientists has warned of a potential pandemic of the neurological condition if ...

Researchers from Karl Landsteiner University of Health Sciences (KL Krems) have discovered that combining two existing drugs ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare.

AI is transforming scientific discovery, but AI researchers aren’t at the forefront. What’s stopping them from taking the ...

Insilico Medicine has completed a Series E round, raising $110m to progress the development of its pipeline of drugs and AI ...